200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 6228-73-5

6228-73-5

6228-73-5 | Cyclopropanecarboxamide

CAS No: 6228-73-5 Catalog No: AG003P6S MDL No:MFCD00013729

Product Description

Catalog Number:
AG003P6S
Chemical Name:
Cyclopropanecarboxamide
CAS Number:
6228-73-5
Molecular Formula:
C4H7NO
Molecular Weight:
85.1045
MDL Number:
MFCD00013729
IUPAC Name:
cyclopropanecarboxamide
InChI:
InChI=1S/C4H7NO/c5-4(6)3-1-2-3/h3H,1-2H2,(H2,5,6)
InChI Key:
AIMMVWOEOZMVMS-UHFFFAOYSA-N
SMILES:
NC(=O)C1CC1
EC Number:
228-332-3
UNII:
NA7A3S4MUT
NSC Number:
402033

Properties

Complexity:
75.6  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
85.053g/mol
Formal Charge:
0
Heavy Atom Count:
6  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
85.106g/mol
Monoisotopic Mass:
85.053g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
43.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.4  

Literature

Title Journal
Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist. Journal of medicinal chemistry 20150611
Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator. Bioorganic & medicinal chemistry letters 20130301
Multi-component anion relay cascade of 1-acetylcyclopropanecarboxamides, aldehydes and acrylonitrile: access to biscyanoethylated furo[3,2-c]pyridinones. Organic & biomolecular chemistry 20120621
Highly asymmetric intramolecular cyclopropanation of acceptor-substituted diazoacetates by Co(II)-based metalloradical catalysis: iterative approach for development of new-generation catalysts. Journal of the American Chemical Society 20111005
Novel series of pyrrolotriazine analogs as highly potent pan-Aurora kinase inhibitors. Bioorganic & medicinal chemistry letters 20110915
Ursodeoxycholic acid amides as novel glucocorticoid receptor modulators. Journal of medicinal chemistry 20110113
Identification of a new biaryl scaffold generating potent renin inhibitors. Bioorganic & medicinal chemistry letters 20101001
Synthesis, antifungal activities and 3D-QSAR study of N-(5-substituted-1,3,4-thiadiazol-2-yl)cyclopropanecarboxamides. European journal of medicinal chemistry 20090701
Synthesis and biological evaluation of cis-locked vinylogous combretastatin-A4 analogues: derivatives with a cyclopropyl-vinyl or a cyclopropyl-amide bridge. Bioorganic & medicinal chemistry letters 20090301
Potential energy scans and vibrational assignments of cyclopropanecarboxylic acid and cyclopropanecarboxamide. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20081215
Effect of Maillard reacted peptides on human salt taste and the amiloride-insensitive salt taste receptor (TRPV1t). Chemical senses 20080901
Modifications of antiepileptic drugs for improved tolerability and efficacy. Perspectives in medicinal chemistry 20080101
Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide series. Bioorganic & medicinal chemistry letters 20070701
Design, synthesis and melatoninergic potency of new N-acyl 8,9-dihydro-4-methoxy-7H-2-benzo[de]quinolinalkanamines. Bioorganic chemistry 20070401
High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor. Journal of medicinal chemistry 20051006
Convergent approach to (E)-alkene and cyclopropane peptide isosteres. Organic letters 20050106
Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56(Lck). Bioorganic & medicinal chemistry letters 20031117
Sequential elimination-cyclopropanation reactions promoted by samarium: highly diastereoselective synthesis of cyclopropylamides. The Journal of organic chemistry 20030207
Discovery and SAR of diarylsulfide cyclopropylamide LFA-1/ICAM-1 interaction antagonists. Bioorganic & medicinal chemistry letters 20010423

© 2019 Angene International Limited. All rights Reserved.